Irhythm Holdings Inc IRTC

$94.24 -0.63 (-0.66%)

Valuation

Market cap
3,189,340,000
Revenue TTM
$747,140,000
Net income TTM
$-44,550,000
P/E (trailing)
66.91
P/E (forward)
113.50
Profit margin
-5.96%
Debt to equity
0.00

Trading

Volume
796,100
Avg volume
726,310
Day's range
$93.99 – $98.65
Shares out
33,618,000
Stochastic %K
70%
Beta
1.39
Analysts
Strong Buy
Price target
$151.65

Price

Company profile

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also prov...

Show more

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Industry
Medical Devices
Sector
Healthcare
Phone
415 632 5700
Website
https://www.irhythmtech.com
Address
699 8th Street, Suite 600, San Francisco, United States

Latest news

Stocktwits

openmarketalerts Nov 19, 11:18 PM
Director Talwalkar Abhijit Y bought $764K of $IRTC stock on Nov 19. Mostly through indirect holdings. • 7,900 shares at $96.67. • Bought 17% above the 52-week low. • Stake up 36%.
0 replies
FilingTracker Nov 19, 10:48 PM
$IRTC Insider purchase: https://filingtracker.ai/filing/1316065/0001316065-26-000016?doc=wk-form4_1795127557.xml
0 replies
openclassaction2 Nov 19, 4:24 PM
$IRTC the $45 million irhythm securities settlement is pending approval, claims closed oct 1, per open class actions. suit alleges false statements about zio at monitors. disclosure ended as a fund
0 replies
TITANPROFIT Nov 18, 4:17 PM
$IRTC 100 CALL 11/20 @ .70 THIS CAN GO 500%+
0 replies
openclassaction2 Nov 18, 12:07 PM
$IRTC the $45 million irhythm securities settlement is pending approval, claims closed, per open class actions. suit alleged false statements about zio at monitors. the monitor had a settlement
0 replies
Rayvio_News_Filter Nov 17, 9:36 PM
$IRTC 🔄 iRhythm Holdings, Inc. entered a $100 million accelerated share repurchase agreement with JPMorgan Chase Bank, National Association under its previously announced $200 million repurchase authorization, receiving an initial delivery of approximately 80% of expected shares. Actionable market event
0 replies
openclassaction2 Nov 17, 3:19 AM
$IRTC the $45 million irhythm securities settlement is pending approval, claims closed oct 1, per open class actions. suit alleged false statements about zio at cardiac monitors
0 replies
openclassaction2 Nov 13, 4:18 AM
$IRTC the $45 million irhythm securities settlement covers alleged false statements about zio at cardiac monitors, claims closed oct 1, per open class actions. seems like the heart monitor story got audited too
0 replies